Clinical Trials · NCT00241020
Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novartis Pharmaceuticals
- Enrollment
- 270
- Start date
- Jun 2002
- Locations
- See registry
- Primary endpoint
- Overall Survival